沙特阿拉伯红细胞增多症患病率及其相关危险因素的叙述性综述。

A narrative review of the prevalence of polycythemia and its associated risk factors in Saudi Arabia.

作者信息

Belali Tareg M

机构信息

Faculty of Applied Medical Sciences, University of Bisha, Al Nakhil, Bisha, Saudi Arabia.

出版信息

Medicine (Baltimore). 2025 Jun 27;104(26):e42959. doi: 10.1097/MD.0000000000042959.

Abstract

As polycythemia is a worldwide health concern, Saudi Arabia is experiencing a notable increase in the prevalence of such a disorder. Studying the frequency and cause of polycythemia is an essential part of implementing successful medical treatments and implementing policies that are possibly going to control this disease. The current review aims to underline the key findings of the body of literature that has examined the causes, prevalence, and major challenges associated with polycythemia in the country and correlate those findings with studies that have been conducted around the world. A comprehensive review of the literature was conducted to summarize the major findings of different studies that have been conducted in Saudi Arabia regarding different types of polycythemias, their causes, symptoms, and associated risk factors, including genetic mutations. Various studies have reported different causes and symptoms of polycythemia. Specific mutations in Janus kinase 2 gene have been found to increase the risk of developing polycythemia vera, according to studies that investigated the genetic component of the disease. Furthermore, reports of common polycythemias such as smoker's, neonatal, and post-transplant polycythemias have been made in different parts of Saudi Arabia. Integrating genetic mutations, demographic information, and clinical manifestations, the current review of the literature offers a comprehensive overview of polycythemia in the kingdom. This benefits polycythemia patients as well as the kingdom by enhancing management techniques, therapeutic approaches, genetic counseling, and the integration of molecular-based diagnostic techniques.

摘要

由于红细胞增多症是一个全球性的健康问题,沙特阿拉伯这种疾病的患病率正在显著上升。研究红细胞增多症的发病频率和病因是实施成功的医学治疗以及制定可能控制这种疾病的政策的重要组成部分。本综述旨在强调已审视该国红细胞增多症的病因、患病率及主要挑战的文献主体的关键发现,并将这些发现与世界各地开展的研究相关联。对文献进行了全面综述,以总结沙特阿拉伯针对不同类型红细胞增多症、其病因、症状及相关风险因素(包括基因突变)所开展的不同研究的主要发现。各项研究报告了红细胞增多症的不同病因和症状。根据对该疾病遗传成分进行调查的研究,已发现Janus激酶2基因的特定突变会增加患真性红细胞增多症的风险。此外,沙特阿拉伯不同地区已有关于常见红细胞增多症(如吸烟者红细胞增多症、新生儿红细胞增多症和移植后红细胞增多症)的报告。综合基因突变、人口统计学信息和临床表现,当前的文献综述对沙特王国的红细胞增多症提供了全面概述。这通过加强管理技术、治疗方法、遗传咨询以及基于分子的诊断技术的整合,使红细胞增多症患者以及沙特王国均受益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/073d/12212794/db259332bee3/medi-104-e42959-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索